# Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients

> **NCT04450108** · NA · COMPLETED · sponsor: **Bosch Healthcare Solutions GmbH** · enrollment: 122 (actual)

## Conditions studied

- Asthma
- Asthma in Children

## Interventions

- **DIAGNOSTIC_TEST:** Vivatmo pro FeNO Test

## Key facts

- **NCT ID:** NCT04450108
- **Lead sponsor:** Bosch Healthcare Solutions GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-08
- **Primary completion:** 2020-12-18
- **Final completion:** 2021-04-13
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04450108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04450108, "Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04450108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*